Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
May 2024;35(5):935-946
Target Audience Target Audience Pharmaceutical Companies Developing Obesity and Metabolic Drugs Oral GLP-1, Dual Incretin and Triple Agonist Drug Developers Biotechnology Companies with Obesity and Cardiometabolic Pipelines Generic Drug Manufacturers Targeting Mature Oral Obesity Therapies CDMOs and API Manufacturers Supporting Oral Peptide and Small Molecule Production Obesity, Endocrinology and Metabolic Disease Clinics Retail, Specialty and Online Pharmacy Chains Telehealth and Digital Weight Management Platforms Health Insurance Companies, PBMs and Reimbursement Decision-Makers Investors, Venture Capital Firms and Strategic Healthcare Investors Suggestions for Related Report Suggestions for Related Report Anti-Obesity Drugs Market Weight loss therapeutics Market Glucagon-like Peptide 1 (GLP-1) Analogues Market Global Diabetes Drugs Market Insulin Resistance Market NASH/MASH Treatment Market Global Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drugs Market Cardiovascular Therapeutics Drugs Market Global Biosimilar Market
It takes a few minutes and replaces the first in-person office visit
This product is not int ended to diagnose, treat, cure or prevent any diseases
US$ 22.39
US$ 25.33
US$ 29.44
US$ 20.91
US$ 24.35
